XYLEM
11.6.2019 11:50:10 CEST | Business Wire | Press release
The International Water Association (IWA) and global water technology company, Xylem (NYSE: XYL) today released a comprehensive white paper titled: “ Digital Water: Industry Leaders Chart the Transformation Journey .”
Examining how digitalisation is transforming the water sector, this important resource provides utility decision makers with actionable learnings to accelerate their adoption of digital solutions and address critical water challenges. The paper also introduces the Digital Water Adoption Curve , a valuable new tool to help utilities assess their digital maturity and map their digital future. Water thought leader and author Will Sarni, CEO, Water Foundry, served as a key author of the report.
Global water challenges, like climate change, population growth, increasing urbanisation and ageing infrastructure, continue to intensify. The latest UN data estimates that 3.6 billion people - almost half the global population - live in areas that are potentially water-scarce at least one month per year and by 2050, more than 5 billion people could suffer water shortages due to climate change, increased demand and polluted supplies. Against this backdrop, water and wastewater utilities are turning to new and innovative solutions including digital technologies, to drive sustainable water management.
“At a time when global water challenges are escalating, digital solutions offer communities around the world bold, new ways to optimise, manage and conserve this most precious resource,” said Kala Vairavamoorthy , IWA Executive Director. “‘Digital Water: Industry Leaders Chart the Transformation Journey’ leverages the insights of IWA members to help utilities learn from their peers, harness the power of digital technologies and enable communities around the world to become more water-secure,” states Kala Vairavamoorthy. “Only together can we shape our water future.”
Patrick Decker , President and CEO of Xylem, said, “The world has to think and act differently about water. There simply is no other choice. Water challenges like scarcity, affordability and resilience are placing millions of human lives at risk, endangering our environment and the global economy, and impeding social progress. These urgent threats are not some far-off problem in the future. They are upon us and growing by the day. We need step-change, and digital innovation is the answer. This paper is a call to action to water stakeholders around the globe. We have the opportunity of a lifetime to solve water and to change history – let’s seize it.”
Valuable lessons from utilities on the digital journey
“Digital Water: Industry Leaders Chart the Transformation Journey” provides valuable insights to water utilities at all stages of digitalisation. The report also shares key utility leaders’ insights in their own voices.
“The world is moving in the direction of technology,” said Richard Appiah Otoo , Chief Technology Officer, Ghana Water Company Limited, one of the nearly 40 utilities that provided input to the white paper. “ Ghana Water experienced a 14 percent increase in revenue after digital technologies increased water bill collection efficiency and provided customers with a mobile billing option.”
Biju George , Executive Vice President, DC Water, commented: “The digital strategy has to become a corporate strategy. It's not an option to sit there and let it happen, you have to plan for it. You have to train your employees towards that, you have to relook at every process. You have to design your systems to give you the data you need to make efficient decisions.”
“If you have any doubt, just try it,” said Claire Falzone , CEO, Nova Veolia-France. “Try small at first if you don't dare to dream big. This is just the beginning of the digital water journey and if you don't adopt digital technologies, someone else will.”
Key take-aways from the report include:
1. Build a holistic digital roadmap and a clear business strategy: Utilities must create internal consensus on how the digital journey will unfold, maintain the customer and business outcomes as focal points throughout the digitalisation process, and educate key stakeholders (consumers, politicians, shareholders, management and employees).
2. Create an innovation culture: Utility operators, IT staff, finance, technicians, executives, and others have to be the scouts for identifying new technologies. However, to drive adoption, utilities must focus on fostering an organisation-wide curiosity and competency for embracing digital innovation.
3. Leverage pilots for an agile mindset: Pilot projects offer a means to explore new technologies, build momentum, and create a more holistic understanding of their physical and financial effects on operations before committing to large-scale implementation.
4. Develop architecture for optimising data use: Developing a data warehouse, where operational data sets become available to functions such as finance, engineering and IT specialists who can use the data to optimise business processes, is critical to creating value from data and effectively digitalising utility infrastructure and connectivity.
NOTES TO EDITORS
About the white paper
The white paper “Digital Water: Industry Leaders Chart the Transformation Journey ” is the first of a series of publications to be developed under the IWA Digital Water Programme. Access the publication here : https://iwa-network.org/projects/digital-water-programme/ .
LAUNCH
The paper is being launched during the 16th IWA Leading Edge Conference on Water and Wastewater Technologies , on Tuesday, 11 June 2019, 10:45 – 11:45 BST - Pentland Auditorium, Edinburgh International Convention Center, Scotland, United Kingdom.
About the IWA Digital Water Programme
The IWA Digital Water Programme aims to act as a catalyst for innovation, knowledge and best practices around digitalisation for the water sector, provide a platform to share experiences and promote leadership in transitioning to digital water solutions, and consolidate lessons to guide the natural evolution from the ‘business as usual’ to achieving a digital water utility. For more information, please visit http://iwa-network.org/projects/digital-water-programme/
About the International Water Association
The International Water Association (IWA) is a network and an international global knowledge hub open to all water professionals and anyone committed to the future of water. With its legacy of over seventy years, it connects water professionals around the world to find solutions to global water challenges as part of a broader sustainability agenda. As a non-profit organization and with a membership in more than 130 countries, the IWA connects scientists with professionals and communities so that pioneering research offers sustainable solutions. In addition, the association promotes and supports technological innovation and best practices through international frameworks and standards. For more information, please visit www.iwa-network.org
About Xylem
Xylem (XYL) is a leading global water technology company committed to developing innovative technology solutions to the world’s water challenges. The Company’s products and services move, treat, analyze, monitor and return water to the environment in public utility, industrial, residential and commercial building services settings. Xylem also provides a leading portfolio of smart metering, network technologies and advanced infrastructure analytics solutions for water, electric and gas utilities. The Company’s approximately 17,000 employees bring broad applications expertise with a strong focus on identifying comprehensive, sustainable solutions. Headquartered in Rye Brook, New York, with 2018 revenue of $5.2 billion, Xylem does business in more than 150 countries through a number of market-leading product brands.
The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at www.xylem.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190611005437/en/
Contact:
For more information and/or interviews please contact: Marta Jimenez, marta.jimenez@iwahq.org , +31 631 93 40 81 Katharine Cross, katharine.cross@iwahq.org , +66 924 53 45 13 Raul Glotzbach, raul.glotzbach@iwahq.org , +31 650 63 75 93 Jenny Rider, jenny.rider@xyleminc.com + 1 914 246 7184 Olivia Dempsey, olivia.dempsey@edelman.com +353 1 678 9333
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom